Related Experiment Video
Updated: Jun 17, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa
Fabien Despas1, A Pathak, M Berry
1INSERM U858 équipe 8, 31432 Toulouse, France. fabien.despas@yahoo.fr
Abstract:
We describe the effects of chronic droxidopa in a patient with Dopamine beta-hydroxylase deficiency diagnosed at the age of 73. Investigations were performed to assess sympathetic activity (MIBG scintigraphy, catecholamines) and cardiovascular droxidopa safety.
Related Concept Videos
Drug Dosing: Geriatric Patients
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Obese Patients
